BR0308378B1 - Medicamento para animais e processo para sua preparação - Google Patents

Medicamento para animais e processo para sua preparação

Info

Publication number
BR0308378B1
BR0308378B1 BRPI0308378-0B1A BR0308378A BR0308378B1 BR 0308378 B1 BR0308378 B1 BR 0308378B1 BR 0308378 A BR0308378 A BR 0308378A BR 0308378 B1 BR0308378 B1 BR 0308378B1
Authority
BR
Brazil
Prior art keywords
preparation
animal medicine
medicine
animal
Prior art date
Application number
BRPI0308378-0B1A
Other languages
English (en)
Portuguese (pt)
Other versions
BR0308378A (pt
Inventor
Hubert Thoma
Uwe Thomas Schote
Ute Isele
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27798784&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BR0308378(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR0308378A publication Critical patent/BR0308378A/pt
Publication of BR0308378B1 publication Critical patent/BR0308378B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Virology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
BRPI0308378-0B1A 2002-03-11 2003-03-10 Medicamento para animais e processo para sua preparação BR0308378B1 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02005511 2002-03-11
PCT/EP2003/002446 WO2003075895A1 (en) 2002-03-11 2003-03-10 Tasted masked veterinary solid compositions

Publications (2)

Publication Number Publication Date
BR0308378A BR0308378A (pt) 2005-01-11
BR0308378B1 true BR0308378B1 (pt) 2013-12-24

Family

ID=27798784

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0308378-0B1A BR0308378B1 (pt) 2002-03-11 2003-03-10 Medicamento para animais e processo para sua preparação

Country Status (22)

Country Link
US (2) US20050169971A1 (enExample)
EP (2) EP1803448A3 (enExample)
JP (1) JP4663985B2 (enExample)
KR (1) KR20040101302A (enExample)
CN (1) CN1652754B (enExample)
AR (1) AR038899A1 (enExample)
AT (1) ATE390129T1 (enExample)
AU (1) AU2003218722B2 (enExample)
BR (1) BR0308378B1 (enExample)
CA (1) CA2478811C (enExample)
CO (1) CO5400144A1 (enExample)
DE (1) DE60319969T2 (enExample)
DK (1) DK1490037T3 (enExample)
ES (1) ES2301784T3 (enExample)
MX (1) MXPA04008845A (enExample)
NZ (1) NZ535167A (enExample)
PT (1) PT1490037E (enExample)
RU (1) RU2318498C2 (enExample)
SI (1) SI1490037T1 (enExample)
TW (1) TWI309557B (enExample)
WO (1) WO2003075895A1 (enExample)
ZA (1) ZA200407010B (enExample)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2556169C (en) * 2004-01-29 2011-11-22 Andrew Lees Use of amino-oxy functional groups in the preparation of vaccines
US8980894B2 (en) 2004-03-25 2015-03-17 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure
EP1579862A1 (en) 2004-03-25 2005-09-28 Boehringer Ingelheim Vetmedica Gmbh Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure
JP2008502727A (ja) * 2004-06-10 2008-01-31 グラット エアー テクニクス インコーポレーテッド 徐放性基材医薬品製剤
WO2005123042A1 (en) * 2004-06-10 2005-12-29 Glatt Air Techniques, Inc. Controlled release pharmaceutical formulation
EP1920785A1 (en) 2006-11-07 2008-05-14 Boehringer Ingelheim Vetmedica Gmbh Liquid preparation comprising a complex of pimobendan and cyclodextrin
EP1935405A1 (en) * 2006-12-22 2008-06-25 LEK Pharmaceuticals D.D. Orally disintegrating tablets
KR20140057604A (ko) 2011-08-12 2014-05-13 베링거잉겔하임베트메디카게엠베하 고양잇과 동물의 심부전을 치료 및 예방하는 방법에 사용하기 위한 퍼니 전류 억제제
AU2012307656B2 (en) 2011-09-15 2016-07-07 Friulchem Spa Compositions for oral administration to animals, production methods thereof and uses of same
CZ308210B6 (cs) * 2011-11-02 2020-03-04 Veterinární A Farmaceutická Univerzita Brno Farmaceutická kompozice ve formě pelet majících velikost částic v rozmezí od 0,1 do 10 mm pro perorální podání vodním živočichům a způsob její výroby
RU2014129508A (ru) 2011-12-21 2016-02-10 Новартис Тиргезундхайт АГ Новая комбинация
WO2013135853A1 (en) * 2012-03-15 2013-09-19 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical packaging product for the veterinary medical sector
US10398705B2 (en) 2012-03-15 2019-09-03 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical tablet formulation for the veterinary medical sector, method of production and use thereof
DK179072B1 (da) * 2012-05-08 2017-10-09 Novartis Tiergesundheit Ag Ny Behandling
FR2991179B1 (fr) 2012-06-01 2016-11-11 Ceva Sante Animale Compositions veterinaires orales appetentes
CA2883139C (fr) 2012-08-31 2021-08-10 Friulchem Spa Compositions pour administration orale aux animaux, leurs procedes d'obtention et leurs utilisations
WO2014053555A1 (en) 2012-10-04 2014-04-10 Novartis Ag Veterinary drug system
FR3002735B1 (fr) 2013-03-04 2015-07-03 Virbac Composition orale nutritionnelle et medicamenteuse a usage veterinaire
FR3002736B1 (fr) 2013-03-04 2015-06-26 Virbac Composition orale nutritionnelle et medicamenteuse a usage veterinaire
AU2014292086B2 (en) 2013-07-19 2019-08-08 Boehringer Ingelheim Vetmedica Gmbh Preserved etherified cyclodextrin derivatives containing liquid aqueous pharmaceutical composition
MX375936B (es) 2013-12-04 2025-03-07 Boehringer Ingelheim Vetmedica Gmbh Composiciones farmaceuticas mejoradas de pimobendan.
KR101687973B1 (ko) * 2015-12-08 2016-12-21 주식회사 씨티씨바이오 마이크로필름 코팅을 이용한 동물 사료용 프리믹스 제조방법
US10537570B2 (en) 2016-04-06 2020-01-21 Boehringer Ingelheim Vetmedica Gmbh Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease
CN105963270B (zh) * 2016-06-30 2019-01-15 齐鲁动物保健品有限公司 一种盐酸贝那普利软咀嚼片及其制备方法
CN109673848A (zh) * 2018-12-29 2019-04-26 广州智特奇生物科技股份有限公司 一种肠溶包被材料、肠道缓释单宁酸及其制备方法
JP7534139B2 (ja) * 2020-07-03 2024-08-14 獣医医療開発株式会社 動物用医薬製剤
CN112220769A (zh) * 2020-08-13 2021-01-15 浙江海正动物保健品有限公司 一种米尔贝肟吡喹酮风味片及其制备方法
AU2021335500A1 (en) 2020-09-04 2023-05-04 Elanco Us Inc. Palatable formulations
US11529310B2 (en) 2020-12-08 2022-12-20 Ruminant Biotech Corp Limited Devices and methods for delivery of substances to animals
CN113768038A (zh) * 2021-09-14 2021-12-10 江苏省协同医药生物工程有限责任公司 一种精准定量实验动物功能性饲料及制备方法与设备
JP7109827B1 (ja) * 2021-11-16 2022-08-01 株式会社ハニック・ホワイトラボ 抗ウイルス剤
CN119033030A (zh) * 2024-09-03 2024-11-29 江西省农业科学院畜牧兽医研究所 一种提高断奶仔猪生产性能的饲料添加剂

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3231466A (en) * 1962-10-26 1966-01-25 Walter H Hoffman Composition and method for treating animals and poultry
US3824233A (en) * 1972-07-06 1974-07-16 Lilly Co Eli Anthelmintic phenylhydrazones
US3937825A (en) * 1973-09-21 1976-02-10 American Cyanamid Company Anthelmintic composition and method of use
US4708867A (en) * 1983-12-19 1987-11-24 Key Pharmaceuticals, Inc. Minipellets
US4800087A (en) * 1986-11-24 1989-01-24 Mehta Atul M Taste-masked pharmaceutical compositions
JPS63188621A (ja) * 1987-01-30 1988-08-04 Taisho Pharmaceut Co Ltd 矯味経口製剤
EP0524180B1 (en) 1990-04-11 1995-04-26 The Upjohn Company Taste masking of ibuprofen by fluid bed coating
WO1993024109A1 (en) 1992-06-04 1993-12-09 Smithkline Beecham Corporation Palatable pharmaceutical compositions
SE9301489D0 (sv) * 1993-04-30 1993-04-30 Ab Astra Veterinary composition
PT760648E (pt) * 1994-05-20 2002-04-29 Janssen Pharmaceutica Nv Tabletes de flubendazole de mastigacao para animais domesticos
SE9402422D0 (sv) 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
SE9600071D0 (sv) * 1996-01-08 1996-01-08 Astra Ab New oral formulation of two active ingredients I
JP4195728B2 (ja) * 1996-10-16 2008-12-10 ナポ ファーマシューティカルズ，インコーポレーテッド プロアントシアニジンポリマー止瀉組成物の腸溶製剤
ES2237121T3 (es) * 1998-07-28 2005-07-16 Takeda Pharmaceutical Company Limited Preparacion solida disgregable rapidamente.
US5997905A (en) * 1998-09-04 1999-12-07 Mcneil-Ppc Preparation of pharmaceutically active particles
US6432448B1 (en) * 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
GB2356346A (en) * 1999-11-19 2001-05-23 Mars Uk Ltd Food product for oral delivery of a pharmaceutical agent to a non-human animal comprising encapsulated particles of said agent distributed within the product
US6541025B1 (en) * 1999-12-30 2003-04-01 Shear/Kershman Laboratories, Inc. Method for preparing solid delivery system for encapsulated and non-encapsulated pharmaceuticals
GB0008332D0 (en) * 2000-04-04 2000-05-24 Pfizer Ltd Treament
BR0207948A (pt) 2001-03-09 2004-07-27 Produits Nestel S A Soc D Composição que melhora os déficits fisiológicos relacionados com a idade e que aumenta a longevidade
US20030190343A1 (en) * 2002-03-05 2003-10-09 Pfizer Inc. Palatable pharmaceutical compositions for companion animals

Also Published As

Publication number Publication date
KR20040101302A (ko) 2004-12-02
TW200304774A (en) 2003-10-16
RU2004130433A (ru) 2005-08-10
ZA200407010B (en) 2006-06-28
JP2005526756A (ja) 2005-09-08
CA2478811C (en) 2010-12-14
CN1652754B (zh) 2013-05-22
SI1490037T1 (sl) 2008-08-31
US20050169971A1 (en) 2005-08-04
JP4663985B2 (ja) 2011-04-06
CA2478811A1 (en) 2003-09-18
CO5400144A1 (es) 2004-05-31
PT1490037E (pt) 2008-05-05
EP1490037A1 (en) 2004-12-29
EP1803448A2 (en) 2007-07-04
EP1803448A3 (en) 2007-09-12
DK1490037T3 (da) 2008-07-21
US20100074952A1 (en) 2010-03-25
WO2003075895A1 (en) 2003-09-18
AR038899A1 (es) 2005-02-02
BR0308378A (pt) 2005-01-11
DE60319969D1 (de) 2008-05-08
RU2318498C2 (ru) 2008-03-10
NZ535167A (en) 2006-08-31
EP1490037B1 (en) 2008-03-26
TWI309557B (en) 2009-05-11
ATE390129T1 (de) 2008-04-15
AU2003218722A1 (en) 2003-09-22
US8617587B2 (en) 2013-12-31
ES2301784T3 (es) 2008-07-01
MXPA04008845A (es) 2004-11-26
AU2003218722B2 (en) 2006-08-31
DE60319969T2 (de) 2009-04-30
CN1652754A (zh) 2005-08-10

Similar Documents

Publication Publication Date Title
PT1562573E (pt) Peletes farmaceuticas compreendendo tamsulosina e processo para a sua producao
PT1325001E (pt) Novos anticolinergicos aplicaveis como medicamentos e processo para a sua preparacao
PT1294682E (pt) Derivados de acilfenilureia processo para a sua preparacao e sua aplicacao como medicamentos
IL164021A (en) Anti-alphavbeta6 antibodies and pharmaceutical compositions containing the same
KR20050009999A (ko) 약제학적 제제
PT1161139E (pt) Etiqueta para animais
PT103029A (pt) Inibidores de dopamina-beta-hidroxilase selectivos perifericamente e metodo para a sua preparacao
ITTO20020741A0 (it) Turbo-ventola e stampo utilizzato per la sua fabbricazione
PT1432417E (pt) Compostos de benzimidazole substituído e sua utilização para o tratamento de cancro
NO20055173D0 (no) Farmasoytisk kombinasjonsblanding omfattende modafinil og et annet legemiddel
DE60302814D1 (de) Vorrichtung für eine tierbezogene Handlung
PT1401397E (pt) Formulacao farmaceutica com sabor mascarado e processo para a sua preparacao
PT1472221E (pt) Indois substituidos, processo para a sua producao e utilizacao na inibicao de dor
IS7798A (is) Efnasambönd, lyfjablöndur og aðferðir
DE60328119D1 (de) Pharmazeutische zubereitungen enthaltend modafinil
BR0215897B1 (pt) prepreg e método para sua produção
PT1053224E (pt) Bifenilsulfonilcianamida, processo para a sua preparacao e sua utilizacao como medicamento
NO20020737D0 (no) Anordning for fiskeoppdrett
PT1361797E (pt) Alimento cremoso e processo para a sua preparacao
PT1157020E (pt) 1,2,3,4,5,6-hexa-hidro-2,6-metano-3-benzazocin-10-ois substituidos processo para a sua preparacao e sua utilizacao como medicamentos
ZA200405282B (en) Hair removal and animal husbandry method.
EP1578305A4 (en) CANIN RANKL AND METHODS OF PREPARATION AND USE THEREOF
PT1372670E (pt) Derivados de caloporosido, processo para a sua preparacao e sua utilizacao
PT102754B (pt) Catecois diterpenicos, processo para a sua preparacao e sua utilizacao
SK3507U (sk) Podporný prípravok pre teľatá a jahňatá

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 24/12/2013, OBSERVADAS AS CONDICOES LEGAIS.

B25C Requirement related to requested transfer of rights

Free format text: A FIM DE ATENDER A TRANSFERENCIA REQUERIDA ATRAVES DA PETICAO NO 20150005907 DE 23/03/2015 , E NECESSARIO REAPRESENTAR O DOCUMENTO DE CESSAO COM AS ASSINATURAS NOTARIZADAS E A DEVIDA LEGALIZACAO CONSULAR.

B25B Requested transfer of rights rejected
B25C Requirement related to requested transfer of rights
B25C Requirement related to requested transfer of rights
B25A Requested transfer of rights approved
B25D Requested change of name of applicant approved
B25G Requested change of headquarter approved